Before revision: EC508 is also under development by Evestra, specifically as an estrogen and potent oral estradiol prodrug for use in menopausal hormone therapy in women and as a hormonal contraceptive to prevent pregnancy in women .
After revision: EC508 is also under development by Evestra, specifically as an estrogen and potent oral estradiol prodrug for use in menopausal hormone therapy in women and as a hormonal contraceptive to prevent pregnancy in women